Article
Genetic editing of primary human dorsal root ganglion neurons using CRISPR-Cas9
1 Apr 2025
Abstract excerpt
CRISPR-Cas9 is now the leading method for genome editing and is advancing for the treatment of human disease. CRIPSR has promise in treating neurological diseases, but traditional viral-vector-delivery approaches have neurotoxicity limiting their use. Here we describe a simple method for non-viral transfection of primary human DRG (hDRG) neurons for CRISPR-Cas9 editing. We edited TRPV1 , NTSR2 , and CACNA1E using...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
